Table 2.
Clinical information of patients in the three groups (i.e., control group, PD group using clonazepam, and PD group not using clonazepam).
| Subject | Control Group (n = 30) |
PD Group w. Clonazepam (n = 12) |
PD Group w.o. Clonazepam (n = 15) |
p-Value |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Age (years) | 61.7 ± 9.2 | 62.5 ± 11.52 | 62.2 ± 8.0 | 0.93 |
| Sex (male/female) | 15/15 | 6/6 | 8/7 | |
| PSQI 1 | 6.66 ± 3.6 | 9.6 ± 5.1 | 11.4 ± 5.7 | 0.006 ** |
| Start sleep (hh:ss) | 22:50 ±66.8 | 21:43 ± 35.5 | 21:53 ± 82.1 | 0.220 |
| End sleep (hh:ss) | 05:36 ± 64.2 | 05:40 ± 70.5 | 05:42 ± 106.7 | 0.792 |
| Sleep time (min) | 364.6 ± 66.2 | 417.5 ± 105.8 | 338 ± 123.4 | 0.090 |
| Bedtime (min) | 434 ± 78.5 | 486.6 ± 65.9 | 470.6 ± 95.2 | 0.120 |
| Sleep efficiency (%) | 85.1 ± 13.4 | 86.5 ± 20.9 | 77 ± 34.8 | 0.445 |
1 PSQI: Pittsburgh Sleep Quality Index; Start sleep and End sleep: twenty-four-hour scale; sleep efficiency: the percentage of sleep time/bedtime; * p < 0.05; ** p < 0.001.